ArticleClinical lung cancer2023

Improved Survival Outcomes in Patients With MET-Dysregulated Advanced NSCLC Treated With MET Inhibitors: Results of a Multinational Retrospective Chart Review.

Jürgen Wolf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.